Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Evonik Is Getting Drug Polymer Line

by Michael McCoy
November 7, 2011 | A version of this story appeared in Volume 89, Issue 45

Evonik Industries will pay $30 million to acquire SurModics’ pharmaceuticals business, which develops drug delivery systems and bioresorbable polymers. Based in Birmingham, Ala., SurModics Pharmaceuticals employs about 80 people and had sales last year of more than $15 million. Evonik says the planned purchase follows the acquisition of Boehringer Ingelheim’s Resomer pharmaceutical polymers business in March and continues the expansion of its drug formulation services business.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.